Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by Sweeetydion Feb 09, 2019 4:25am
281 Views
Post# 29341407

Health Canada

Health CanadaTo anyone of the belief that Tetra weren’t testing their drug lots for the entirety of the trial, you need to read HCs policy on CTs.  Tetra wouldn’t have been given the green light to commence trials and continue if they weren’t. The tests weren’t positive for toxins until the test lot from 20 Dec 2018 returned. 

The positive from this unfortunate situation is that no patients received contaminated drugs and that phase 3 is completed/ won’t need to be repeated.

Alright, so there’s a delay.  We have an NDA application for 002 coming anyday. Perhaps that’s what TBP are anticipating.  The NR from Thursday certainly gets across that having one DIN can really increase valuation, so 002 will be our first.



<< Previous
Bullboard Posts
Next >>